Please see our news in the archive to the right.
Raising MIOCA's Voice in Washington, D.C.
March 12, 2015
Eighty survivors and supporters from across the country gathered in Washington D.C. on March 10, 2015 for Ovarian Cancer Advocacy Day. With ten women attending from Michigan, the state was well represented at this event organized by the Ovarian Cancer National Alliance. Six of the ten women received an advocacy travel scholarship from the Lori Haber Buckfire Foundation. MIOCA is very grateful for the support of our advocacy efforts.
MIOCA advocates were able to meet with staff from several Senate and House offices. Survivors and supporters shared personal stories and detailed the need for ovarian cancer research funding. Additionally, the need for funding of ovarian cancer education and awareness was discussed.
For those who couldn't travel to DC, both OCNA and MIOCA encourage you to contact Senator Stabenow, Senator Peters, and your US Representative. Please see MIOCA's advocate page for more information.
MIOCA Announces Geri Fournier Ovarian Cancer Research Grant Recipients
March 3, 2015
MIOCA is proud to announce the recipients of the inaugural Geri Fournier Ovarian Cancer Research Grant awards. MIOCA is committed to advocating for women and working for improved treatment outcomes. One way we further our mission is to fund innovative ovarian cancer research. In September, 2014, MIOCA donated $5,000 to the newly announced Ovarian Cancer Dream Team. This year, because of tremendous support from donors, MIOCA's Board of Directors is thrilled to provide $25,000 to fund research here in Michigan through the Geri Fournier Ovarian Cancer Research Grant awards.
Lan Gardner Coffman, M.D., PhD $10,000
University of Michigan Health System
Defining the origin and role of carcinoma-associated mesenchymal stem cells in the ovarian cancer microenvironment
Karen McLean, MD, PhD $10,000
Assistant Professor, Gynecologic Oncology
Translational Oncology Program
University of Michigan Heatlh System
Therapeutic Inhibition of the DEK Oncoprotein in Epithelial Ovarian Cancer
Ramandeep Rattan, PhD $5,000
Division Gynecologic Oncology
Henry Ford Hospital
A preclinical trial of olaparib and metformin in BRCA intact ovarian cancer mouse model
MIOCA wishes to thank these scientists and the other applicants for their efforts to discover ways in which ovarian cancer patients can be treated more successfully.